Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.

Outsource API manufacturing to India for lower costs, GMP-compliant quality, scalable production, and faster time-to-market for pharma companies.

Peak Technology Unveils APEX: A Product Development & Realization Platform Designed to Provide Deep Tech OEMs with Rapid Prototyping, New Product Introduction, and High Volume Manufacturing Solutions ...

India hosts more active pharmaceutical ingredient (API) manufacturing sites that are compliant with the U.S. Food and Drug Administration than any country outside the U.S., and it produces more ...